Abstract
One of the tools presently under investigation to achieve site specific drug delivery is the combination of drug-containing liposomes and antibodies (so-called immunoliposomes). The potentials and limitations of this form of targeted chemotherapy are discussed, followed by an example of the use of drug-loaded immunoliposomes in the intracavitary therapy of ovarian carcinoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, T.M., Hansen, C. and Rutledge, J. (1989). Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim. Biophys. Acta 981: 27–35.
Aragnol, D. and Leserman, L.D. (1986). Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo. Proc. Natl. Acad. Sci. USA 83: 2699–2703.
Bast Jr., R.C. and Knapp, R.C. (1987). The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinoma. Important Adv. Oncol. 39–53.
Blok, M.C., van der Neut-Kok, E.C.M., van Deenen, L.L.M. and de Gier, J. (1975). The effect of chain length and liquid phase transition on the selective permeability of liposomes. Biochim. Biophys. Acta 406: 187–196.
Bodor, N. and Brewster, M.E. (1986). Problems of delivery of drugs to the brain. In: Methods of Drug Delivery. (G.M. Ihler, ed.), Pergamon Press, Oxford, pp. 153–202.
Boerman, O., Makldnk, W., Massuger, L., Thomas, C., Kenemans, P., Hanselaar, T. and Poels, L. (1989). Monoclonal antibodies against ovarian carcinoma-associated antigens, raised by immunization with cyst fluid. Anticancer Res. 9: 551–558.
Collins, D. and Huang, L. (1987). Cytotoxicity of diphtheria toxin A fragment to toxin-resistant murine cells delivered by pH-sensitive immunoliposomes. Cancer Res. 47: 735–739.
Connor, J., Yatvin, M.B. and Huang, L. (1984). pH-sensitive liposomes: Acid-induced liposome fusion. Proc. Natl. Acad. Sci. USA 81: 1715–1718.
Connor J., Sullivan, S. and Huang, L. (1985). Monoclonal antibody and liposomes. Pharmacol. Ther. 28: 341–365.
Durrant, L.G., Robins, R.A., Armitage, N.C., Brown, A., Baldwin, R.W. and Hardcastle, J.D. (1986). Association of antigen expression and DNA ploidy in human colorectal tumors. Cancer Res. 46: 3542–3549.
Forssen, E.A. and Tökés, Z.A. (1983). Attenuation of dermal toxicity of doxorubicin by liposome encapsulation. Cancer Treat. Rep. 67: 481–484.
Gabizon, A. and Papahadjopoulos, D. (1988). Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 85: 6949–6953.
Gitman, A.G. and Loyter, A. (1984). Construction of fusogenic vesicles bearing specific monoclonal antibodies. J. Biol. Chem. 259: 9813–9820.
Greiner, J.W., Horan Hand, P., Colcher, D., Weeks, M., Thor, A., Noguchi, P., Petska, S. and Schlom, J. (1987). Modulation of human tumour antigen expression. J. Lab. Clin. Med. 109: 244261.
Hakomori, S. and Kannagi, R. (1983). Glycosphingolipids as tumor-associated and differentiation markers. J. Natl. Cancer Inst. 71: 231–251.
Heath, T.D. (1988). Liposome dependent drugs. In: Liposomes as Drug Carriers. Recent Trends and Progress. G. Gregoriadis (Ed.), John Wiley & Sons, Chichester, pp. 709–718.
Heath, T.D., Fraley, R.T., Bentz, J., Voss Jr., E.W., Herron, J.N. and Papahadjopoulos, D. (1984). Antibody-directed liposomes. Determination of affinity constants for soluble and liposome-bound antifluorescein. Biochim. Biophys. Acta 770: 148–158.
Ho, R.J.Y., Rouse, B.T. and Huang, L. (1986). Target-sensitive immunoliposomes: preparation and characterization. Biochemistry 25: 5500–5506.
Kirby, C.J., Clarke, J. and Gregoriadis, G. (1980). Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serum. FEBS Lett. 111: 324–328.
Markman, M. (1986). Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity. Cancer Treat. Rep. 13: 219–242.
Martin, F.J. and Papahadjopoulos, D. (1982). Irreversible coupling of immunoglobulin fragments to preformed vesicles. J. Biol. Chem. 257: 286–288.
Moseley, K.R., Battaile, A., Knapp, R.C. and Haisma, HJ. (1988). Localization of radiolabelled F(ab’)2 fragments of monoclonal antibodies in nude mice bearing intraperitoneally growing human ovarian cancer xenografts. Int. J. Cancer 42: 368–372.
Nässander, U.K., Storm, G., Peeters, P.A.M. and Crommelin, D.J.A. (1990). Liposomes. In: Biodegradable Polymers as Drug Delivery Systems. (Langer, R. and Chasin, M. eds.), Marcel Dekker, Inc., in press.
Nayar, R., Fidler, I.J. and Schroit, A.J. (1988). Potential application of pH-sensitive liposomes as drug delivery systems. In: Liposomes as Drug Carriers. (G. Gregoriadis, ed.), John Wiley and Sons Ltd, pp. 771–782.
Ohkuma, S. and Poole, B. (1978). Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75:3327–3331
Peeters, P.A.M., Storm, G. and Crommelin, D.J.A. (1987). Immunoliposomes in vivo: state of the art. Adv. Drug Del. Rev. 1: 249–266.
Poels, L.G., Peters, D., van Megen, Y., Vooijs, G.P., Verheyen, R.N.M., Willemen, A., van Niekerk, C.C., Jap, P.H.K., Mungyer, G. and Kenemans, P. (1986). Monoclonal antibody against human ovarian tumor-associated antigens. J. Natl. Cancer Inst. 76: 781–791.
Poste, G., Bucane, C., Raz, A., Bugelski, P., Kirsh, R. and Fidler, I.J. (1982). Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res. 42: 1412–1422.
Poste, G. (1983). Liposome targeting in vivo: problems and opportunities. Biol. Cell. 47: 19–38.
Scatchard, G. (1949). The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51: 660–672.
Scherphof, G.L., Roerdink, F., Dijkstra, J., Ellens, H., Zanger de, R. and Wisse, E. (1983). Uptake of liposomes by rat and mouse hepatocytes and Kupffer cells. Biol. Cell. 47: 47–58.
Scherphof, G.L. (1986). Liposomes in biology and medicine. In: Lipids and Membranes: Past, Present and Future. (J.A.F. Op den Kamp, B. Roelofsen and K.W.A. Wirtz, eds.), Elsevier, Amsterdam, pp. 113–136.
Senior, J.H. (1987). Fate and behavior of liposomes in vivo: A review of controlling factors. CRC Critical Reviews in Therapeutic Drug Carrier Systems 3: 123–193.
Storm, G., Oussoren, C. and Peeters, P.A.M. (1990). Safety of liposome administration. In: Membrane Lipid Oxidation. Vol. 3 (C. Vigo-Pelfrey, ed.), C.R.C. Press, Boca Raton, Florida. In press.
Sullivan, S.M., Connor, J. and Huang, L. (1986). Immunoliposomes: Preparation, properties, and applications. Med. Res. Rev. 6: 171–195.
Tagliabue, E., Menard, S., Della Torre, G., Barbanti, P., Mariani-Costantini, R., Porro, G. and Colnaghi, M.I. (1985). Generation of monoclonal antibodies reacting with human epithelial ovarian cancer. Cancer Res., 45: 379–385.
Thigpen, J.T., Vance, R.B. and Lambuth, B.W. (1988). Ovarian carcinoma: the role of chemotherapy. Sem. Oncol. 15: 16–23.
Toonen, P.A.H.M. and Crommelin, D.J.A. (1983). Immunoglobulins as targeting agents for liposome-encapsulated drugs. Pharm. Weekbl. Sci. Ed. 5: 269–280.
Torchilin, V.P. (1985). Liposomes as targetable drug carriers. CRC Critical Reviews in Therapeutic Drug Carrier Systems 2: 65–115.
Tycko, B. and Maxfield, F.R. (1982). Rapid acidification of endocytic vesicles containing a macroglobulin. Cell 28: 643–648.
Wright, S. and Huang, L. (1989). Antibody-directed liposomes as drug-delivery vehicles. Adv. Drug Del. Rev. 3: 343–389.
Yatvin, M.B., Weinstein, J.N., Dennis, W.H. and Blumenthal, R. (1978). Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202:1290–1293.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Nässander, U.K. et al. (1990). Immunoliposome-Mediated Delivery of Chemotherapeutics. In: Crommelin, D.J.A., Schellekens, H. (eds) From Clone to Clinic. Developments in Biotherapy, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3780-5_44
Download citation
DOI: https://doi.org/10.1007/978-94-011-3780-5_44
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5683-0
Online ISBN: 978-94-011-3780-5
eBook Packages: Springer Book Archive